TWO SIGMA INVESTMENTS, LP - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$51,383
-63.6%
25,312
-58.7%
0.00%
Q2 2023$140,997
-87.4%
61,303
-83.4%
0.00%
-100.0%
Q1 2023$1,120,424
+2283.9%
369,777
+1412.9%
0.00%
Q3 2022$47,000
-86.8%
24,442
-79.5%
0.00%
-100.0%
Q1 2022$355,000
-89.7%
119,081
-86.6%
0.00%
-85.7%
Q4 2021$3,445,000
+10.0%
885,537
+21.3%
0.01%0.0%
Q3 2021$3,133,000
+307.4%
730,298
+187.7%
0.01%
+250.0%
Q2 2021$769,000
-70.0%
253,823
-67.0%
0.00%
-71.4%
Q1 2021$2,561,000
+396.3%
769,051
+171.3%
0.01%
+133.3%
Q2 2020$516,000
+140.0%
283,507
+33.5%
0.00%
+50.0%
Q1 2020$215,000
-15.0%
212,400
+133.8%
0.00%
+100.0%
Q4 2019$253,000
+644.1%
90,864
+302.1%
0.00%
Q3 2019$34,000
-81.4%
22,599
-74.4%
0.00%
-100.0%
Q2 2019$183,000
-19.4%
88,106
+39.1%
0.00%0.0%
Q1 2019$227,000
+13.5%
63,334
+21.0%
0.00%0.0%
Q4 2018$200,000
-12.7%
52,344
+116.2%
0.00%0.0%
Q3 2018$229,000
-56.9%
24,211
-66.7%
0.00%
-50.0%
Q2 2018$531,000
+147.0%
72,714
+70.4%
0.00%
+100.0%
Q4 2017$215,00042,6650.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 3,705,128$10,300,0004.44%
RTW INVESTMENTS, LP 5,666,754$15,754,0000.59%
COWEN AND COMPANY, LLC 926,200$2,575,0000.22%
Hudson Bay Capital Management LP 850,000$2,363,0000.05%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,774,915$4,934,0000.03%
Point72 Asset Management, L.P. 1,897,284$5,274,0000.03%
683 Capital Management, LLC 77,368$215,0000.02%
Secure Asset Management, LLC 10,000$28,0000.02%
Qube Research & Technologies Ltd 166,138$462,0000.01%
Verition Fund Management LLC 174,455$485,0000.01%
View complete list of ARBUTUS BIOPHARMA CORP shareholders